✦ LIBER ✦

Pig plasma α-protease inhibitors PI2, PI3 and PI4 are members of the antichymotrypsin family

✍ Scribed by A. Stratil; D. Čižová-Schröffelová; E. Gábrišová; M. Pavlik; W. Coppieters; L. Peelman; A. Van de Weghe; Y. Bouquet

Book ID: 116127316
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 821 KB
Volume: 111
Category: Article
ISSN: 1096-4959
DOI: 10.1016/0305-0491(94)00232-j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of 3-(2-aminoethyl)-5-(3-pheny

Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways

✍ Qianbin Li; Jingde Wu; Hui Zheng; Kai Liu; Tai L. Guo; Yuying Liu; Scott T. Eble 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 710 KB

A thiazolidine-2,4-dione derivative, 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione (2), was identified as a dual inhibitor of the Raf/MEK/ extracellular signal-regulated kinase (ERK) and the phosphatidylinositol 3-kinase (PI3K)/Akt signaling cascades. The discovered compound inhib

CKD712, (S)-1-(α-naphthylmethyl)-6,7-dih

CKD712, (S)-1-(α-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, inhibits the lipopolysaccharide-stimulated secretion of HMGB1 by inhibiting PI3K and classical protein kinase C

✍ Young Joo Oh; Ju Ho Youn; Hyun Jin Min; Dal-Hyun Kim; Sung-Sook Lee; In-Hong Cho 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 784 KB

Discovery of 5-(2-amino-[1,2,4]triazolo[

Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease

✍ Mihiro Sunose; Kathryn Bell; Katie Ellard; Giovanna Bergamini; Gitte Neubauer; T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 604 KB

ChemInform Abstract: Discovery of 5-(2-A

ChemInform Abstract: Discovery of 5-(2-Amino-[1,2,4]triazolo [1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a Potent, Orally Bioavailable and Selective Inhibitor of PI3K for the Treatment of Inflammatory Disease.

✍ Sunose, Mihiro; Bell, Kathryn; Ellard, Katie; Bergamini, Giovanna; Neubauer, Git 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 23 KB